Profile: IPGDx LLC is a biotechnology firm dedicated at providing healthcare & derivative technologies to help patients to live a better life and physicians & caregivers make improved healthcare decisions. Our PrognostiCheck® device provides a reliable and objective prognosis measurement. It is a proprietary noninvasive measurement that depicts prognosis by illustrating the plasma cell membrane and the exchange between the intra & extra cellular matrices. We use impedance plethysmography, a well-established vascular diagnostic technique to measure the values of resistance (R) and Reactance (Xc) and calculate Phase Angle (Pa). Phase Angle is the arc tangent of Xc/R converted to degrees. Phase angle determined by PrognostiCheck® detects changes in tissue electrical properties and is a reliable & objective prognostic indicator in several chronic conditions such as HIV prognosis, liver cirrhosis prognosis, cancer prognosis, chronic obstructive pulmonary disease prognosis, breast cancer prognosis, colorectal cancer prognosis, pancreatic cancer prognosis & lung cancer prognosis and in patients receiving dialysis. KBDMS™ is a knowledge based disease management system. It is logic based computerized disease management methods.